Can low-density Blastocystis still stimulate intestinal mucosal immunity?

Mechanistic immune pathways

• Subpatent antigen shedding: Even during low-density colonization where fecal microscopy is negative and sensitive PCR reveals low copy numbers, Blastocystis actively sheds luminal antigens, including surface proteins and active proteases, into the intestinal tract.
• Mucosal immune polarization: These antigens directly interface with the host mucosal surface. In asymptomatic carriers, they promote immune tolerance via regulatory, Th2-skewed pathways involving interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β). In symptomatic individuals, these same antigens drive pro-inflammatory Th17 responses, elevate mucosal interleukin-8 (IL-8), disrupt tight junctions, and increase epithelial permeability.

Mucosal antibody dynamics and evasion

• Humoral activation: Active mucosal stimulation by these parasite-derived antigens triggers the secretion of antigen-specific secretory immunoglobulin A (sIgA) into the intestinal lumen.
• Protease-mediated degradation: To counteract this defense, Blastocystis secretes active cysteine and aspartic proteases. These enzymes directly cleave and degrade human sIgA within the lumen, establishing a dynamic equilibrium that can suppress net fecal sIgA levels despite ongoing mucosal immune activation.

Bottom line

• Even at low, microscopy-negative densities, Blastocystis functions as an active luminal antigen capable of modulating host mucosal immunity and altering fecal sIgA levels through a balance of adaptive immune stimulation and protease-mediated antibody degradation.